← back to search

Yan Wang

North Sichuan Medical University · CN
Area of research
Reproductive Medicine · Gastroenterology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, RNA modifications and cancer, Gastrointestinal Tumor Research and Treatment, and Gastrointestinal motility and disorders.
h-index
31
citations
3,672
works
260
NIH funding
primary concept
email

Recent publications

Spatiotemporal dynamics of benzylisoquinoline alkaloid gene expression and co-expression networks during Papaver Somniferum developmental stages
Scientific Reports 2025cited by 3position: middledoi
Abstract CT119: Safety and efficacy of HS-10370 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
Cancer Research 2024cited by 6position: middledoi
Application of the birthrate plus (BR+) methodology to identify midwifery workforce shortages in China: a retrospective multisite study
Interdisciplinary Nursing Research 2023cited by 1position: middledoi
Effects of mFOLFOX6 regimen combined with carrelizumab on immune function and prognosis in patients with microsatellite instability colorectal cancer
Cellular and Molecular Biology 2022cited by 9position: lastdoi
The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study
Clinical Medicine Insights Oncology 2022cited by 4position: middledoi
Preliminary results of a phase 1b study of fruquintinib plus sintilimab in advanced colorectal cancer.
Journal of Clinical Oncology 2021cited by 21position: middledoi
Case Fatality Risk of the First Pandemic Wave of Coronavirus Disease 2019 (COVID-19) in China
Clinical Infectious Diseases 2020cited by 66position: middledoi
FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
Oncology Letters 2019cited by 9position: firstdoi
PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis
Scientific Reports 2017cited by 233position: middledoi
EphB3 protein is associated with histological grade and FIGO stage in ovarian serous carcinomas
Apmis 2017cited by 10position: middledoi
EGF-reduced<i>Wnt5a</i>transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells
Oncotarget 2015cited by 57position: middledoi
<i>KRAS</i> exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer
Future Oncology 2015cited by 11position: middledoi
The predictive value of pre-and postoperative neutrophil-lymphocyte ratio for pulmonary large cell neuroendocrine carcinoma patients
Zhonghua shiyan waike zazhi 2014cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Hui Gong · Ningbo University1 papers (2020–2020)Yueyin Pan · Anhui Medical University1 papers (2021–2021)Qiong Wu · Union Hospital1 papers (2024–2024)Yongchang Chen · Sun Yat-sen University Cancer Center1 papers (2015–2015)Hongli Zhao · Harbin Medical University1 papers (2017–2017)Jing Li · Fujian Medical University1 papers (2020–2020)Pengpeng Lü · Nantong University1 papers (2022–2022)Hong Wang · Beijing Institute of Technology1 papers (2015–2015)Rui Xu · Guangzhou University of Chinese Medicine1 papers (2015–2015)Huijun Zhu · Shanghai Medical College of Fudan University1 papers (2019–2019)Jie Sun · Nantong University1 papers (2022–2022)Siheng Lin · Southern Medical University1 papers (2024–2024)Xiu Zhu · King University1 papers (2023–2023)Jianchao Zheng · Wenzhou Medical University1 papers (2015–2015)Weiwei Gao · Nantong University1 papers (2017–2017) · 1 papers (2023–2023)Ruyan Pang · Chinese Medical Association1 papers (2023–2023)Weiguo Su · China Banking Regulatory Commission1 papers (2021–2021) · 1 papers (2021–2021)Hongying Wei · Guangxi Medical University1 papers (2024–2024)